Green Tea Consumption and the Risk of Liver Cancer: A Meta-Analysis

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA: Cancer J Clin 65(2), 87–108, 2015.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran R, Limaye A, and Cabrera R: Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepatic Med: Evidence Res 4, 19–37, 2012.
   PubMedGoogle Scholar
• Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, et al.: Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 103(22), 1686–1695, 2011.
   PubMedGoogle Scholar
• Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, et al.: A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44(6), 1074–1082, 2006.
   PubMed Web of Science ®Google Scholar
• Yang XW, Wang XL, Cao LQ, Jiang XF, Peng HP, et al.: Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells. Hepatol res 42(5), 494–501, 2012.
   PubMed Web of Science ®Google Scholar
• Qin G, Gopalan-Kriczky P, Su J, Ning Y, and Lotlikar PD: Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett 112(2), 149–154, 1997.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Shirakami Y, Sakai H, Kubota M, Kochi T, et al.: Chemopreventive potential of green tea catechins in hepatocellular carcinoma. Int J Mol Sci 16(3), 6124–6139, 2015.
   PubMed Web of Science ®Google Scholar
• Liang G, Tang A, Lin X, Li L, Zhang S, et al.: Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37(1), 111–123, 2010.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Ehlers SJ, Lee JY, Fernandez ML and Koo SI: Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr 139(4), 640–645, 2009.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kumazoe M, Kim Y, Yamashita S, Nakahara K, et al.: Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Sci Rep 3, 2749, 2013.
   PubMed Web of Science ®Google Scholar
• Lee LS, Choi JH, Sung MJ, Hur JY, Hur HJ, et al.: Green tea changes serum and liver metabolomic profiles in mice with high-fat diet-induced obesity. Mol Nutr Food Res 59(4), 784–794, 2015.
   PubMed Web of Science ®Google Scholar
• Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, et al.: Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65(4), 331–341, 2009.
   PubMed Web of Science ®Google Scholar
• Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, et al.: Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 31(6), 469–484, 2008.
   PubMed Web of Science ®Google Scholar
• Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, and Yang CS: Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 48(1), 409–416, 2010.
   PubMed Web of Science ®Google Scholar
• Forester SC, and Lambert JD: The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 55(6), 844–854, 2010.
   Web of Science ®Google Scholar
• Wells GA, O'Connell D, and Peterson J: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2014. http://www.ohri.ca/programs/clinical_epide–miology/oxford.asp
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, and Altman DG: Measuring inconsistency in meta-analyses. BMJ (Clin Res ed) 327(7414), 557–560, 2003.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed) 315(7109), 629–634, 1997.
   PubMed Web of Science ®Google Scholar
• Jarl J, and Gerdtham UG: Time pattern of reduction in risk of oesophageal cancer following alcohol cessation–a meta-analysis. Addiction 107(7), 1234–1243, 2012.
   PubMed Web of Science ®Google Scholar
• Greenland S, and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11), 1301–1309, 1992.
   PubMed Web of Science ®Google Scholar
• Tang N, Wu Y, Zhou B, Wang B, and Yu R: Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 65(3), 274–283, 2009.
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr., Lee KL, and Pollock BG: Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80(15), 1198–1202, 1988.
   PubMedGoogle Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al.: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15), 2008–2012, 2000.
   PubMed Web of Science ®Google Scholar
• Butler LM, Huang JY, Wang R, Lee MJ, Yang CS, et al.: Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study. Am J Epidemiol 181(6), 397–405, 2015.
   PubMed Web of Science ®Google Scholar
• Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, et al.: Study on the protective effect of green tea on gastric, liver and esophageal cancers. Chin J Prev Med 37, 171–173, 2003( in Chinese).
   Google Scholar
• Nechuta S, Shu XO, Li HL, Yang G, Ji BT, et al.: Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 96(5), 1056–1063, 2012.
   PubMed Web of Science ®Google Scholar
• Li Y, Chang SC, Goldstein BY, Scheider WL, Cai L, et al.: Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol 35(4), 362–368, 2011.
   PubMed Web of Science ®Google Scholar
• Wang JY, Zhu L, Wu DL, Wang XS, Li DH, et al.: Matched case-control study on factors for main cancer in a low incidence area of Jiangsu province. Chin J Cancer Prev Treat 15, 565–568, 2008 ( in Chinese).
   Google Scholar
• Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, et al.: Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes Control: CCC 20(10), 1939–1945, 2009.
   PubMed Web of Science ®Google Scholar
• Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, et al.: Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidem Biomar 18(6), 1746–1753, 2009.
   PubMed Web of Science ®Google Scholar
• Wang N, Zheng Y, Jiang Q, Yu X, and Chen Y: Tea and reduced liver cancer mortality. Epidemiology 19(5), 761, 2008.
   PubMed Web of Science ®Google Scholar
• Wu HB, Ming HT, Liu AM, Gu XP, Chen J, et al.: Case-control study on factors for liver cancer in a high incidence area of Jiangsu province. Jiangsu Prev Med 23, 26–28, 2012( in Chinese).
   Google Scholar
• Nagano J, Kono S, Preston DL, and Mabuchi K: A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki(Japan). Cancer Causes Control: CCC 12(6), 501–508, 2001.
   PubMed Web of Science ®Google Scholar
• Kang H, Rha SY, Oh KW, and Nam CM: Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol Health 32, 1–8, 2010.
   Google Scholar
• Gallo E, Maggini V, Berardi M, Pugi A, Notaro R, et al.: Is green tea a potential trigger for autoimmune hepatitis? Phytomedicine 20(13), 1186–1189, 2013.
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL: Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 144(1), 68–71, 2006.
   PubMed Web of Science ®Google Scholar
• Jin X, Zheng RH, and Li YM: Green tea consumption and liver disease: a systematic review. Liver Int 28(7), 990–996, 2008.
   PubMed Web of Science ®Google Scholar
• Fon Sing M, Yang WS, Gao S, Gao J, and Xiang YB: Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev 20(3), 157–165, 2011.
   PubMed Web of Science ®Google Scholar
• Desquilbet L, and Mariotti F: Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29(9), 1037–1057, 2010.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu X, Wu Y, and Zhang D: Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies. Lung Cancer 78(2), 169–170, 2012.
   PubMed Web of Science ®Google Scholar
• Tang L, Tang M, Xu L, Luo H, Huang T, et al.: Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 29(2), 411–417, 2008.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang X, Lu G and Picinich SC: Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9(6), 429–439, 2009.
   PubMed Web of Science ®Google Scholar
• Joan LB: Green Tea and Cancer in Humans: A Review of the Literature. Nutr Cancer 31(3), 151–159, 1998.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang D, Feng N, Chen G, Liu J, et al.: Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis. Gastroenterology 147(5), 1031–1042, 2014.
   PubMed Web of Science ®Google Scholar
• Bravi F, Bosetti C, Tavani A, Gallus S, and La Vecchia C: Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 11(11), 1413–1421, 2013.
   PubMed Web of Science ®Google Scholar